Literature DB >> 8464812

Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds.

Y Tabata1, R Langer.   

Abstract

A new method to prepare polyanhydride microspheres capable of near-constant sustained release of low molecular weight, water-soluble molecules is presented. The polyanhydrides used were poly(fatty acid dimer) (PFAD), poly(sebacic acid) (PSA), and their copolymers [P(FAD-SA)]. Acid orange 63 (AO), acid red 8 (AR), and p-nitroaniline, were used as model release molecules. P(FAD-SA) microspheres containing the molecules with or without gelatin were prepared by a modified solvent evaporation method using a double emulsion. The microspheres were spherical with diameters of 50-125 microns and encapsulated more than 85% of the molecule, irrespective of the compound used. Near-zero-order degradation kinetics were observed for 5 days as judged by sebacic acid (SA) release. Microsphere degradation was pH sensitive, being enhanced at high pH, and became more stable in acidic conditions, irrespective of the incorporation of gelatin in the matrix. For the gelatin-free microspheres, a close correlation of SA release and AO release was observed (2% loading), suggesting a release mechanism that was controlled dominantly by degradation. However, the incorporation of gelatin into the microsphere significantly extended the periods of molecule release from P(FAD-SA) microspheres, although the degradation profile of the microspheres themselves was quite similar to that of gelatin-free microspheres. It is possible that an interaction between FAD monomers and gelatin molecules causes continued release, even after the polymer matrix completely degrades (even after complete degradation, FAD monomers remain because of their poor water solubility). Thermal analysis of polyanhydride microspheres at different degradation stages demonstrated that a crystalline structure was formed between gelatin and the FAD monomers produced with microsphere degradation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464812     DOI: 10.1023/a:1018988222324

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

Review 1.  Present and future applications of biomaterials in controlled drug delivery systems.

Authors:  R S Langer; N A Peppas
Journal:  Biomaterials       Date:  1981-10       Impact factor: 12.479

Review 2.  Controlled release of biologically active compounds from bioerodible polymers.

Authors:  J Heller
Journal:  Biomaterials       Date:  1980-01       Impact factor: 12.479

3.  Polyanhydride microsphere formulation by solvent extraction.

Authors:  C Bindschaedler; K Leong; E Mathiowitz; R Langer
Journal:  J Pharm Sci       Date:  1988-08       Impact factor: 3.534

4.  Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics.

Authors:  K W Leong; B C Brott; R Langer
Journal:  J Biomed Mater Res       Date:  1985-10

5.  Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.

Authors:  H Brem; M S Mahaley; N A Vick; K L Black; S C Schold; P C Burger; A H Friedman; I S Ciric; T W Eller; J W Cozzens
Journal:  J Neurosurg       Date:  1991-03       Impact factor: 5.115

  5 in total
  6 in total

Review 1.  Nano-enabled delivery of diverse payloads across complex biological barriers.

Authors:  Kathleen A Ross; Timothy M Brenza; Andrea M Binnebose; Yashdeep Phanse; Anumantha G Kanthasamy; Howard E Gendelman; Aliasger K Salem; Lyric C Bartholomay; Bryan H Bellaire; Balaji Narasimhan
Journal:  J Control Release       Date:  2015-08-24       Impact factor: 9.776

2.  Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.

Authors:  Timothy M Brenza; Shivani Ghaisas; Julia E Vela Ramirez; Dilshan Harischandra; Vellareddy Anantharam; Balaraman Kalyanaraman; Anumantha G Kanthasamy; Balaji Narasimhan
Journal:  Nanomedicine       Date:  2016-10-19       Impact factor: 5.307

Review 3.  Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines.

Authors:  Surya K Mallapragada; Timothy M Brenza; JoEllyn M McMillan; Balaji Narasimhan; Donald S Sakaguchi; Anup D Sharma; Svitlana Zbarska; Howard E Gendelman
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

4.  Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis.

Authors:  F X Lacasse; M C Filion; N C Phillips; E Escher; J N McMullen; P Hildgen
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

5.  Development and characterization of microencapsulated microspheres.

Authors:  A Göpferich; M J Alonso; R Langer
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

6.  Controlled delivery systems for proteins using polyanhydride microspheres.

Authors:  Y Tabata; S Gutta; R Langer
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.